Fiserv acquires fee and billing software developer Interactive Technologies Inc.
Milwaukee Brookfield-based Fiserv, Inc. , has acquired Interactive Technologies, Inc., a developer of fee management and billing software for large and mid-sized financial services organizations, for an undisclosed sum. Interactive Technologies, headquartered in Summit, New Jersy, develops s...Emerging game developer begins work on prototypes
Green Bay, Wis. - With the support of a local equity investor, an early-stage video game software design company recently launched pre-production game development, and it is intent on marketing its games to major publishers such as Microsoft , Sony , and Nintnedo . Selling its products to t...Milwaukee software developer gains bottom line, loses waistline
Wauwatosa, Wis. - John Psuik became a triathlon athlete only three years ago, but his Milwaukee-based mobile software products company has been engaged in a simple marathon since opening in 1996. And now, the route of that marathon has taken a sharp turn toward Europe and Asia. Psuik, f...Alzheimer's drug developer lands $1.2M in venture funding
Madison, Wis . - Mithridion, Inc ., a biopharmaceutical start up that is developing drugs to disrupt the progress of Alzheimer's disease, has closed an additional $1.2 million of Series A funding led by Madison's Venture Investors . The latest round of funding brings the total equity capital ...Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox
Key words: neurite outgrowth • cell-by-cell • fluorescent image analysis • IN Cell Analyzer • IN Cell Developer Toolbox Neurite extension, or neurite outgrowth, plays a fundamental role in embryonic development, neuronal differentia...Brady Corp. acquires software developer
MILWAUKEE -- Brady Corp., a Milwaukee-based identification, safety, graphic systems and specialty materials manufacturer, has acquired a California visitor security software developer. Brady did not disclose the terms of the acquisition of STOPware, Inc. , of San Jose. STOPware, founde...M&I forms partnership with Illinois software developer
MILWAUKEE -- Marshall & Ilsley Corp . announced Wednesday it has formed a strategic partnership with Plansmith Corp . of Schaumburg, Ill., to expand its services to other financial institutions. With the partnership, M&I will use Plansmith's Compass brand asset liability management (ALM) so...Metavante to buy California software developer
Milwaukee, Wis. - Metavante Corp ., the banking and payments technology subsidiary of Marshall and Ilsley Corp ., is in the final stages of acquiring VICOR, Inc. , a Richmond, Calif.-based provider of corporate payment processing software. VICOR is being pursued, in part, to enable Metavant...Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
...s led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary Note for Forward-Looking Statements. Th...ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA
...ing exceptional customer service and product support. In recent years, ALPCO has solidified its place in the market not only as a distributor but as a developer and manufacturer of immunoassays as well. CONTACT: Kate Kaplan 800-592-5726 ...GeoVax Labs, Inc. Provides Clinical Studies Update
...l form of the virus envelope glycoprotein as well as protective T cells. "Vaccine trials can be a slow process," said Harriet Robinson, Ph.D., developer of the vaccine and Senior V.P. of Research and Development. "The therapeutic trials should move more rapidly than the preventative trials because each...SK Life Sciences has Licensed Pristima
... Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion Medical Systems, a world leader in toxicology and pathology data management solutions and the developer of Pristima™ the premier preclinical solution on the market, is pleased to announce that SK Life Science, Inc. (SKLSI), has licensed Pristima fo...Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores
... BEIJING, Aug. 3 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (OTC Bulletin Board: YGII; "Yongye" or the "Company"), a leading developer and distributor of Shengmingsu branded plant and animal nutrient products located in the People's Republic of China, today announced that the number o...Millions Flowing into Medical Real Estate
...ement team and the assets that we’re buying and developing,” Lillibridge CFO Joe Kurzydym told HREI. Meanwhile, Nashville, Tenn.-based developer Oman-Gibson Associates says it is looking to raise $40 million from investors, and then leverage new medical real estate developments and acquisitions...Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
... NEW YORK, July 30 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company and a leading developer of oncology compounds directed to cancer stem cell targets, today announced that the Company's CEO, Ivan Bergstein M.D. has been invited to present at...Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
...icals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmac...tp://www.lotuspharma.com ) Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharma...Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
... BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner III of Sofinnova Ventures and Ha...Cynosure Reports Second Quarter 2009 Financial Results
... WESTFORD, Mass., July 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three months ended June 30, 20...Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer
...NEW YORK, July 23 /PRNewswire-USNewswire/ -- Exosome Diagnostics, Inc., the developer of non-invasive molecular oncology diagnostics to aid in early cancer detec...rapies." About Exosome Diagnostics Exosome Diagnostics is a developer of proprietary molecular diagnostic tests with applications in oncology and...Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
...s on a project, it succeeds." About Cellular Dynamics International, Inc. Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem ce...BioMS Medical announces second quarter 2009 results
... Toronto Stock Exchange Symbol: MS EDMONTON, July 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the three and six months ended June 30, 2009. "Th...Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
...vider of strategic advisory services to life sciences companies, where he most recently served as President and CEO of BioMedical Enterprises, Inc., a developer and marketer of orthopaedic memory metal implants. Previously, he was Managing Director, Healthcare Investment Banking at ThinkEquity Partners. In 1...Sinovac Adjourns 2008 Annual General Meeting
... BEIJING, July 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, announced today that its Annual General Meeting originally scheduled for July 16, 2009 has been adjourned to July 3...Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
... propofol sedation if they have brain monitoring, says Dr. Barry Friedberg, developer of PK anesthesia. The huge, 19-fold variation in propofol detox between pat... propofol sedation if they have brain monitoring, says Dr. Barry Friedberg, developer of PK anesthesia. The huge, 19-fold variation in propofol detox betw...Novel handheld device detects anthrax with outstanding accuracy and reliability
... Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technolo...Cellular Dynamics International Reprograms Blood Cells into Stem Cells
...ity to differentiate into any cell type. About Cellular Dynamics International, Inc. Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem ce...New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue
... CAMBRIDGE, Mass., July 6 /PRNewswire/ -- OmniGuide, Inc., the developer of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, today announced the results of a pre-clinical study ...Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
...zation such as Roche in this endeavour." About Cellular Dynamics International, Inc. Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem ce...EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements
...o market Chromax(R) chromium picolinate in Europe . PURCHASE, N.Y., June 30 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI ), the developer and marketer of nutritional supplements under the Iceland Health(R) and Diabetes Essentials brands, announced today that the European Food Safety Auth...Novavax Appoints Stanley Erck to Board of Directors
...f experience in the biotechnology and health-care industries and served most recently as President and Chief Executive Officer of Iomai Corporation, a developer of vaccines and immune system therapies that was acquired in 2008 by Intercell. Previously, Mr. Erck was President and Chief Executive Officer of Pro...BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests
...incorporation of Lumiphore's Lumi4(R)-Tb complexes in BRAHMS diagnostic tests. Under the agreement, BRAHMS together with its subsidiary Cezanne, developer and manufacturer of KRYPTOR automated diagnostic solutions, has the non-exclusive rights to incorporate Lumi4(R) technology into current and future di...